ETView Medical Ltd. (TASE: ETVW) has successfully combined airway management with continuous direct airway visualization for medical professionals. ETView's patented VivaSight™-SL, a single-use disposable medical device, consisting of a single lumen ventilation tube with an integrated continuous high-resolution video imaging system is currently sold in Europe, Israel, and the United States to overcome current limitations and associated adverse surgical events during lung isolation surgeries.
ETView products are extensively protected by both US and international patents, both issued and pending.
who we are
 |
Bill Edelman, CEO, is a medical device industry executive with over 33 years of experience and currently serves as Chairman of the Board for Leviticus Cardio, Ltd., (cardiac assist power systems), Co-Chairman for ETView, Ltd., (TASE: ETVW) (airway management), Chairman of the Board for Medivalve, Ltd., (percutaneous aortic valve placement) and Cardioflow, Ltd., (embolic protection). Mr. Edelman also serves as an Advisor on the Heathcare Board for Northeast Securities, Inc., a member of the Screening Committee, Medical Devices for Mass Medical Angels, a member of the Advisory Council for the Department of Biomedical Engineering at Rensselaer as well as an Advisor to Highland Instruments, Inc., and MindChild Medical, Inc. Mr. Edelman recently served as Chairman of the Board for PolyTouch, Ltd. (general surgical instrumentation) and Stimatix GI, Ltd., Previously, Mr. Edelman served as President & Chief Executive Officer, TYRX, Inc., a commercial stage venture-backed medical device company focused in drug/device implant products for general surgery, electrophysiology, and cosmetic surgery. Prior to TYRX, Mr. Edelman held executive level positions at MicroSense International, LLC (bio-sensing), FibraSonics, Inc. (ultrasonic surgical products), NeuroMod, Inc. (neuro-stimulation technologies), St. Jude Medical, Inc. (NYSE: STJ), Pfizer, Inc. (NYSE: PFE), and Baxter International, Inc. (NYSE: BAX). Mr. Edelman graduated with a degree in Biomedical Engineering from Rensselaer Polytechnic Institute. He has been issued 15 US patents and is an applicant on 3 additional pending patent applications.
|
 |
D. Todd Dollinger, Chairman, has more than 20 years of experience in the medical device industry. Mr. Dollinger is the Chairman and CEO of The Trendlines Group, one of Israel’s top medical device investment companies; he serves as chairman and as a member of the board of directors of a number of Trendlines’ portfolio companies.
|
E-mail Bill Edelman: